nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiplatelets for secondary stroke prevention in China
|
Wu, Simiao |
|
|
22 |
6 |
p. 457-459 |
artikel |
2 |
A sensitive portrayal of a controversial condition
|
Stirrups, Robert |
|
|
22 |
6 |
p. 473 |
artikel |
3 |
Aspiring to restore arm and hand function after stroke
|
Hayward, Kathryn S |
|
|
22 |
6 |
p. 464-465 |
artikel |
4 |
A study in healing the wounds of trauma
|
Morgan, Jules |
|
|
22 |
6 |
p. 472 |
artikel |
5 |
Autoimmune encephalitis: chasing a moving target
|
Venkatesan, Arun |
|
|
22 |
6 |
p. 460-462 |
artikel |
6 |
Boston criteria version 2.0 and non-haemorrhagic presentations
|
Moura, João |
|
|
22 |
6 |
p. 466 |
artikel |
7 |
Boston criteria version 2.0 and non-haemorrhagic presentations – Authors' reply
|
Charidimou, Andreas |
|
|
22 |
6 |
p. 466-467 |
artikel |
8 |
Correction to Lancet Neurol 2023; 22: 368–69
|
|
|
|
22 |
6 |
p. e8 |
artikel |
9 |
Correction to Lancet Neurol 2023; 22: 373–74
|
|
|
|
22 |
6 |
p. e8 |
artikel |
10 |
Correction to Lancet Neurol 2023; 22: 505–16
|
|
|
|
22 |
6 |
p. e8 |
artikel |
11 |
Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease
|
Dalmau, Josep |
|
|
22 |
6 |
p. 529-540 |
artikel |
12 |
Elisaveta Sokolov
|
|
|
|
22 |
6 |
p. 471 |
artikel |
13 |
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial
|
Pan, Yuesong |
|
|
22 |
6 |
p. 485-493 |
artikel |
14 |
Monomania of political strife by Géricault
|
Burgos, Javier S |
|
|
22 |
6 |
p. 468-469 |
artikel |
15 |
Neurological research in children: challenges and misconceptions
|
Sanger, Terry |
|
|
22 |
6 |
p. 474-475 |
artikel |
16 |
Peter Goadsby: knowledge of politics, politics of knowledge
|
Burton, Adrian |
|
|
22 |
6 |
p. 470 |
artikel |
17 |
Rimegepant for migraine: acute efficacy beyond the USA
|
Mitsikostas, Dimos D |
|
|
22 |
6 |
p. 456-457 |
artikel |
18 |
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
|
Yu, Shengyuan |
|
|
22 |
6 |
p. 476-484 |
artikel |
19 |
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
|
Furr Stimming, Erin |
|
|
22 |
6 |
p. 494-504 |
artikel |
20 |
Stroke care quality—why recognition matters
|
Van Der Merwe, Jan |
|
|
22 |
6 |
p. 471 |
artikel |
21 |
Targeting tau degradation: a viable therapeutic approach?
|
Mason, Matthew |
|
|
22 |
6 |
p. 462-464 |
artikel |
22 |
The Brain Research Africa Initiative (BRAIN)
|
Njamnshi, Alfred K |
|
|
22 |
6 |
p. 467-468 |
artikel |
23 |
The complexities underlying epilepsy in people with glioblastoma
|
Sokolov, Elisaveta |
|
|
22 |
6 |
p. 505-516 |
artikel |
24 |
Traumatic brain injury as a chronic disease: insights from the United States Traumatic Brain Injury Model Systems Research Program
|
Dams-O'Connor, Kristen |
|
|
22 |
6 |
p. 517-528 |
artikel |
25 |
Treatment for Alzheimer's disease: time to get ready
|
The Lancet Neurology, |
|
|
22 |
6 |
p. 455 |
artikel |
26 |
Valbenazine as treatment for Huntington's disease chorea
|
Heim, Beatrice |
|
|
22 |
6 |
p. 459-460 |
artikel |